Intravenous push medications in the home

Journal of Intravenous Nursing

Volumn 22, Issue 4, 1999, Pages 209-215

  Poole, Susan Markel ^a   Nowobilski Vasilios, Anna ^b   Free, Fran ^b  

^a Prof Services for Option Care Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; HOME CARE; HUMAN; NURSING; PATIENT SATISFACTION; PHLEBITIS; PROFESSIONAL PRACTICE;

ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY HEALTH NURSING; HOME INFUSION THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; RETROSPECTIVE STUDIES;

EID: 0033366643     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Garrelts JC, Ast D, LaRocca J, Smith DF, Peterie JD. Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agents. Clin Pharm 1988;7:760-5.
2. Garrelts JC, Smith DF, Ast D, Peterie JD. A comparison of the safety, timing and cost-effectiveness of administering antibiotics by intravenous bolus (push) versus intravenous piggyback (slow infusion) in surgical prophylaxis. Pharmacoeconomics 1992;2:116-23.
3. Jones LA, Gonzales E, Reines H, et al. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration. Annals of Pharmacotherapy 1994;28:841-4.
4. Kreitman TM, Grass CA. IV push antibiotics: alternative method of drug administration. Presented at American Society for Health System Pharmacists (ASHP) Midyear Clinical Meeting, Las Vegas, December 7, 1995.
5. St. Peter W, Lambrecht LJ, Marcres M. Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28(4):523-8.
6. Sherry PO, Sweeney CW. Incidence of phlebitis in oncology patients. Journal of Vascular Access Networks 1993;3:9-10,14-7.
7. Markowsky S. Automatic therapeutic substitution cost savings with intravenous push famotidine [letter]. Annals of Pharmacotherapy 1995;29:316.
8. Gura KM. Parenteral drug administration guidelines for the pediatric patient: one hospital's recommendations. Hospital Pharmacy 1993;28:221-3,227-8,231-6,239-42.
9. Phelps SJ, Cochran EB. Guidelines for Administration of Intravenous Medications to Pediatric Patients. 4th ed. Bethesda, MD: American Society of Health System Pharmacists, 1993.
10. Robinson DC, Cookson TL, Grisafe JA. Concentration guidelines for parenteral antibiotics in fluid-restricted patients. Drug Intell Clin Pharm 1987;21:985-9.
11. Santiero ML, Sagraves R, Allen LV. Osmolality of small-volume i.v. admixtures for pediatric patients. Am J Hosp Pharm 1990;47: 1359-64.
12. Trissel LA. Handbook on Injectable Drugs. 8th ed. Bethesda, MD: American Society of Health System Pharmacists, 1994.
13. Van Arsdale RW. Incorrect information about azlocillin precipitation in Handbook of Injectable Drugs. Am J Hosp Pharm 1990;47: 76.
14. Terry J, Baranowski L, Lonsway R, Hedrick C (Eds). Intravenous Therapy Clinical Principles and Practice. Philadelphia: WB Saunders, 1995.